Stevanato Group S.p.A.

STVN

Exchange: NYSE
Industry: Surgical & Medical Instruments & Apparatus
SEC CIK: 0001849853

SEC filings (opens in a new tab)

In the last 90 days, Stevanato Group S.p.A. insiders filed 0 open-market purchases and 4 sales; 125 institutions reported holding it in 13F filings for Q2 2026, worth $808.8M in total; no superinvestor holds it.

Q4 2021 vs. Q3 2021

How the institutions holding Stevanato Group S.p.A. changed between Q3 2021 and Q4 2021.

All holders in Q4 2021 All holders in Q3 2021

13F holders of STVN: Q3 2021 compared with Q4 2021
Measure	Q3 2021	Of which not filed for Q4 2021	Q4 2021	Change
Holders	60	1	80	+21
Shares	34.4M	14.3K	36.3M	+1.91M (+5.6%)
Value	$869.8M	$361.0K	$814.2M	−$55.3M (−6.4%)

1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so the changes leave them out.

New holders (32)

Institutions that held Stevanato Group S.p.A. at the end of Q4 2021 but not at the end of Q3 2021.

Institutions new to STVN in Q4 2021
Institution	Shares	Value	% of portfolio
Bamco Inc	487,200	$10.9M	0.02%
Nicholas Company, Inc.	401,315	$9.01M	0.15%
Magnetar Financial LLC	238,830	$5.36M	0.05%
Tri Locum Partners LP	226,700	$5.09M	2.04%
Allspring Global Investments Holdings, LLC	183,214	$4.11M	0.00%
Advantage Alpha Capital Partners LP	155,344	$3.49M	0.50%
Bank Julius Baer & Co. Ltd, Zurich	144,403	$3.24M	0.02%
Brinker Capital Investments, LLC	127,527	$2.86M	0.04%
Alliancebernstein L.P.	77,500	$1.74M	0.00%
Arrowstreet Capital, Limited Partnership	73,310	$1.65M	0.00%
Moore Capital Management, LP	50,000	$1.12M	0.03%
TownSquare Capital, LLC	40,547	$910.0K	0.02%
Boothbay Fund Management, LLC	37,423	$840.0K	0.03%
Schonfeld Strategic Advisors LLC	32,276	$725.0K	0.01%
PDT Partners, LLC	25,923	$582.0K	0.04%
Winton Group Ltd	19,091	$429.0K	0.03%
Jump Financial, LLC	17,549	$394.0K	0.02%
First Bank & Trust	13,430	$302.0K	0.13%
Acadian Asset Management LLC	12,672	$284.0K	0.00%
Paloma Partners Management Co	9,709	$218.0K	0.01%
JPMorgan Chase & Co	8,740	$196.0K	0.00%
Parallel Advisors, LLC	8,294	$186.0K	0.01%
Cooper Investors Pty Ltd	5,261	$118.1K	0.01%
Emerald Mutual Fund Advisers Trust	5,160	$116.0K	0.00%
Russell Investments Group, Ltd.	4,164	$93.0K	0.00%
HM Payson & Co	787	$18.0K	0.00%
Amundi	682	$12.0K	0.00%
State of Wyoming	287	$6.00K	0.00%
Legal & General Group Plc	239	$5.00K	0.00%
Citigroup Inc	28	$1.00K	0.00%
Lee Financial Co	34	$1.00K	0.00%
Simplex Trading, LLC	18	$0	0.00%

Sold out (11)

Institutions that held Stevanato Group S.p.A. at the end of Q3 2021 and filed for Q4 2021 without it.

Institutions that sold out of STVN in Q4 2021
Institution	Shares, Q3 2021	Value, Q3 2021
PFM Health Sciences, LP	549,002	$13.9M
Caas Capital Management LP	300,000	$7.59M
Mirabella Financial Services LLP	220,904	$5.59M
Tekla Capital Management LLC	137,872	$3.49M
MYDA Advisors LLC	130,000	$3.29M
Roubaix Capital, LLC	121,599	$3.08M
Alpha Paradigm Partners, LLC	46,222	$1.17M
BlueCrest Capital Management Ltd	34,938	$884.0K
Cubist Systematic Strategies, LLC	33,299	$843.0K
Chiron Investment Management, LLC	21,836	$553.0K
Tudor Investment Corp Et Al	15,530	$393.0K

Not filed for Q4 2021 yet (1)

Institutions that held Stevanato Group S.p.A. at the end of Q3 2021 and haven't filed a 13F for Q4 2021. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding STVN in Q3 2021 that haven't filed for Q4 2021
Institution	Shares, Q3 2021	Value, Q3 2021
Marshall Wace North America L.P.	14,306	$361.0K